Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?

Edyta Maria Urbanska; Jens Benn Sørensen; Eric Santoni-Rugiu

doi:10.1016/j.jtho.2022.11.028

Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?

Edyta Maria Urbanska^*, Jens Benn Sørensen, Eric Santoni-Rugiu

^*Corresponding author af dette arbejde

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Vol/bind	18
Udgave nummer	3
Sider (fra-til)	e28-e29
ISSN	1556-0864
DOI	https://doi.org/10.1016/j.jtho.2022.11.028
Status	Udgivet - mar. 2023

Adgang til dokumentet

10.1016/j.jtho.2022.11.028

Andre filer og links

Link to publication in Scopus

Citationsformater

Urbanska, E. M., Sørensen, J. B., & Santoni-Rugiu, E. (2023). Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 18(3), e28-e29. https://doi.org/10.1016/j.jtho.2022.11.028

Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? / Urbanska, Edyta Maria; Sørensen, Jens Benn; Santoni-Rugiu, Eric.
I: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Bind 18, Nr. 3, 03.2023, s. e28-e29.

Publikation: Bidrag til tidsskrift › Letter › peer review

Urbanska, EM, Sørensen, JB & Santoni-Rugiu, E 2023, 'Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?', Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, bind 18, nr. 3, s. e28-e29. https://doi.org/10.1016/j.jtho.2022.11.028

Urbanska, Edyta Maria ; Sørensen, Jens Benn ; Santoni-Rugiu, Eric. / Efficacy of Brigatinib After Progression on Alectinib or Ceritinib : Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?. I: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2023 ; Bind 18, Nr. 3. s. e28-e29.

@article{998ffe260e7c4d3489f53ad40d63769a,

title = "Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?",

keywords = "Humans, Lung Neoplasms/drug therapy, Carcinoma, Non-Small-Cell Lung/drug therapy, Carbazoles/pharmacology, Receptor Protein-Tyrosine Kinases, Protein Kinase Inhibitors/therapeutic use",

author = "Urbanska, {Edyta Maria} and S{\o}rensen, {Jens Benn} and Eric Santoni-Rugiu",

year = "2023",

month = mar,

doi = "10.1016/j.jtho.2022.11.028",

language = "English",

volume = "18",

pages = "e28--e29",

journal = "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",

issn = "1556-0864",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - Efficacy of Brigatinib After Progression on Alectinib or Ceritinib

T2 - Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?

AU - Urbanska, Edyta Maria

AU - Sørensen, Jens Benn

AU - Santoni-Rugiu, Eric

PY - 2023/3

Y1 - 2023/3

KW - Humans

KW - Lung Neoplasms/drug therapy

KW - Carcinoma, Non-Small-Cell Lung/drug therapy

KW - Carbazoles/pharmacology

KW - Receptor Protein-Tyrosine Kinases

KW - Protein Kinase Inhibitors/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=85148721769&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2022.11.028

DO - 10.1016/j.jtho.2022.11.028

M3 - Letter

C2 - 36842817

SN - 1556-0864

VL - 18

SP - e28-e29

JO - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

JF - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

IS - 3

ER -